OnKure Therapeutics, Inc.
OKUR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $114,719 | $221,434 | $310,808 | $155,127 |
| - Cash | $110,761 | $29,876 | $11,543 | $124,660 |
| + Debt | $1,085 | $674 | $637 | $0 |
| Enterprise Value | $5,043 | $192,232 | $299,902 | $30,467 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$50 |
| % Margin | – | – | – | – |
| EBITDA | -$51,711 | -$34,751 | -$29,379 | -$39,720 |
| % Margin | – | – | – | – |
| Net Income | -$52,673 | -$35,311 | -$29,512 | -$39,770 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.95 | -2.65 | -2.21 | -21.92 |
| % Growth | -49.1% | -19.9% | 89.9% | – |
| Operating Cash Flow | -$51,117 | -$34,546 | -$26,953 | -$37,983 |
| Capital Expenditures | -$52 | -$246 | -$1,134 | -$198 |
| Free Cash Flow | -$51,169 | -$34,792 | -$28,087 | -$38,181 |